Introduction {#S1}
============

Mammalian oocytes develop over a long period, spanning up to several decades in humans. Their development starts before birth in the embryo. The oocytes are initially very small and are stored for long periods in the ovary. Periodically, some oocytes become activated. They grow in size and accumulate mRNAs and proteins, which are required for embryo development ([@R15]). When the oocytes have reached their full size, they are capable of maturing into a fertilizable egg. This maturation is triggered once every menstrual cycle by a surge of luteinizing hormone (LH). The surge of LH leads to the activation of the important cell-cycle regulator Cyclin-dependent kinase 1 in complex with its co-activator Cyclin B (Cdk1/CycB). This complex is also known as the maturation promoting factor (MPF). Upon activation, Cdk1/CycB phosphorylates a large number of targets that drive the reinitiation of meiosis. These factors include proteins of the nuclear lamina, whose phosphorylation triggers nuclear envelope breakdown (NEBD) ([@R2]; [@R42]), as well as spindle assembly factors ([@R19]; [@R44]; [@R67]). Because the mechanism of Cdk1/CycB activation in meiosis is similar to the canonical prophase pathway that activates Cdk1/CycB in mitosis, the meiotic arrest is also called prophase arrest ([@R59]). Several mechanisms restrict Cdk1/CycB activity during prophase arrest in mouse oocytes. The co-activator Cyclin B turns over constantly, and its absence ensures low Cdk1/CycB activity ([@R35]; [@R45]; [@R57]). In addition, inhibitory phosphorylations on Cdk1 decrease its activity. These phosphorylations are controlled by a regulatory network that responds to LH. The kinases WEE1 and MYT1 maintain the inhibitory phosphorylations on Cdk1 ([@R21]; [@R39]). The phosphatase CDC25 counteracts them but is inactive during the meiotic arrest ([@R49]; [@R51]). Upon a surge of LH, WEE1 and MYT1 are inactivated ([@R20]). This initially activates a small pool of Cdk1/CycB, which subsequently phosphorylates and activates CDC25. This ultimately results in full Cdk1/CycB activation, which is a prerequisite to exit the meiotic arrest.

Failure to exit the meiotic arrest has been implicated in female infertility ([@R25]; [@R47]; [@R58]). Understanding the mechanisms that control meiotic resumption is thus of medical relevance. Current research on meiotic resumption mainly focuses on protein kinases and the protein phosphatases PP1 and PP2A ([@R1]; [@R23]). We recently performed a large-scale RNAi screen to identify genes that are involved in the regulation of mammalian meiosis ([@R52]). Through this screen, we identified dual-specificity phosphatase (DUSP) 7 as a phosphatase that is essential for the resumption of meiosis.

DUSP7 is a cytoplasmic phosphatase and was identified as mitogen-activated protein kinase-phosphatase (MKP). DUSP7 is known to dephosphorylate the p42/p44 mitogen-activated protein kinases (p42/p44 MAPKs, better known as ERK1/2), which inactivates them ([@R6]). Generally, DUSPs binds to their targets via a conserved arginine-rich kinase interaction motif, which is located amino-terminally of the phosphatase domain ([@R5]). Little is known about the function of DUSP7. In acute leukemia, DUSP7 is frequently overexpressed ([@R38]), but its physiological role is still unknown.

We show here that DUSP7 is essential for two crucial steps of oocyte meiosis: first, it is required for timely NEBD to facilitate the reinitiation of meiosis; second, it is essential for accurate chromosome segregation. We establish the mechanisms by which DUSP7 fulfills these functions and attribute a physiological role to DUSP7 during development.

Results {#S2}
=======

DUSP7 Depletion in Mouse Oocytes Delays and Prevents Meiotic Resumption {#S3}
-----------------------------------------------------------------------

We depleted DUSP7 by culturing small interfering RNA (siRNA)-injected oocytes within follicles in vitro ([Figure S1A](#SD2){ref-type="supplementary-material"}). This system is particularly well suited to deplete stable proteins in mouse oocytes, because it prevents protein synthesis from an early stage of oocyte growth onward ([@R52]). In short, small immature oocytes that are surrounded by cumulus cells (follicles) were isolated from female mice around 11 days after birth. After microinjection with siRNAs against DUSP7 and subsequent culture for 10 days ex vivo, the fully grown and mature oocytes were stripped of the cumulus cells and microinjected a second time with mRNAs encoding fluorescent reporter proteins and rescue constructs. We then followed meiosis by high-resolution live cell microscopy.

First, we verified that our follicle culture system is suitable to study the regulation of cell-cycle events by comparing in vivo and in vitro grown oocytes. In both groups, the activity of the E3 ubiquitin ligase anaphase promoting complex/cyclosome (APC/C) was comparable ([Figure S1B](#SD2){ref-type="supplementary-material"}). In addition, the levels of important cell-cycle regulators such as the kinase Cdk1 and the phosphatase CDC25B are similar ([Figure S1C](#SD2){ref-type="supplementary-material"}). This is consistent with our previous study that showed that meiosis progresses in a similar manner in in vitro and in vivo grown oocytes and that the transcriptome of both groups is closely related ([@R52]). Altogether, these data suggest that oocytes that were cultured within follicles in vitro are suitable to study the meiotic cell cycle.

DUSP7-depleted oocytes were frequently unable to undergo NEBD, the first visible sign of meiotic resumption ([Figures 1A and 1B](#F1){ref-type="fig"}; [Figures S1D--S1G](#SD2){ref-type="supplementary-material"}). This phenotype was specifically due to the depletion of DUSP7, because GFP-tagged wildtype DUSP7 (DUSP7^wt^) rescued NEBD. A catalytically inactive version of DUSP7 (C333S, DUSP7^c.i.^) did not rescue NEBD, indicating that the catalytic activity of DUSP7 is essential for its function ([Figure 1B](#F1){ref-type="fig"}). Those DUSP7-depleted oocytes that still underwent NEBD did so with a delay of around 2 hr ([Figure 1C](#F1){ref-type="fig"}). The timing of NEBD in DUSP7-depleted oocytes that expressed GFP-tagged wild-type DUSP7 was still slower than in control oocytes ([Figure 1C](#F1){ref-type="fig"}). This is likely due to a partial rescue by GFP-tagged wild-type DUSP7, which allowed a larger number of oocytes to progress into meiosis ([Figure 1B](#F1){ref-type="fig"}) but did not fully restore the timing of NEBD in these rescued oocytes due to decreased levels of Cdk1/CycB activity, as we discuss in more detail later.

Next, we wanted to identify the targets of DUSP7 that drive the release from prophase arrest. To this end, we created a DUSP7 mutant that can no longer interact with ERK1/2 and tested whether this mutant can rescue the DUSP7 depletion phenotype. The DUSP7 residues that are essential for the interaction with ERK1/2 were not known, but they were previously shown for DUSP6, a close relative of DUSP7 ([@R62]). By sequence alignment, we identified arginine 104 and arginine 105 in the kinase interaction motif of DUSP7 as the likely residues that are essential for the interaction with ERK1/2. We then performed co-immunoprecipitation assays in HeLa cells expressing ERK2, together with the FLAG-tagged DUSP7 mutant (R104/105M, MAPK binding mutant, DUSP7^MBM^) or other FLAG-tagged DUSP7 (FLAG-DUSP7) variants ([Figure 1D](#F1){ref-type="fig"}). DUSP7^wt^ and catalytically inactive DUSP7 bound efficiently to ERK2. In contrast, DUSP7^MBM^ did not bind to ERK2, confirming that we had identified the correct residues ([Figure 1D](#F1){ref-type="fig"}). We then expressed similar levels of wild-type DUSP7, as well as DUSP7^MBM^, in DUSP7-depleted oocytes ([Figure S1H](#SD2){ref-type="supplementary-material"}). DUSP7-depleted oocytes that expressed DUSP7^MBM^ underwent NEBD with the same high efficiency as oocytes expressing DUSP7^wt^ ([Figures 1B and 1C](#F1){ref-type="fig"}). This indicates that DUSP7's function in NEBD does not require its interaction with ERK1/2. These data are unexpected given that no other targets of DUSP7 besides ERK1/2 are known. However, consistent with this finding, previous studies reported that ERK1/2 are only activated after NEBD in mouse oocytes. This renders a function of ERK1/2 in NEBD unlikely ([@R8]; [@R10]; [@R65]).

An In Vitro Phospho-peptide Screening Assay Identified cPKC Isoforms as DUSP7 Substrates {#S4}
----------------------------------------------------------------------------------------

We speculated that other, so far unknown substrates of DUSP7 could drive meiotic resumption. To identify these substrates, we carried out an in vitro phospho-peptide screening assay. In this assay, synthetic 12--13 amino acid-long peptides with a phosphorylated serine, threonine, or tyrosine residue are incubated with a phosphatase. If the phosphatase dephosphorylates a peptide, the phosphate moiety is released and detected by a chelating solution that changes color upon phosphate binding. We purified active DUSP7 from bacteria and performed five independent in vitro dephosphorylation assays. We then focused on protein substrates that were found in at least three of the assays ([Figure 2A](#F2){ref-type="fig"}). In this way, we identified Ephrin type-A receptors (Epha), phospholipase C gamma 1 (PLCγ1), and different conventional protein kinase C (cPKC) isoforms as DUSP7 substrates. RNAi-mediated targeting of these proteins did not result in a detectable phenotype ([Figures S2A--S2C](#SD2){ref-type="supplementary-material"}). However, previous studies suggested that activation of cPKC isoforms, for example, by Phorbol 12-myristate 13-acetate (PMA), a highly potent activator of cPKC isoforms, delays meiotic resumption in mouse oocytes ([@R13]; [@R36]). We confirmed that PMA delays meiotic entry, mimicking the DUSP7 depletion phenotype ([Figures 2B--2D](#F2){ref-type="fig"}). In addition, the specific upregulation of cPKC activity by overexpressing constitutively active PKCβ2^A25E^ ([@R22]) delayed NEBD to a similar extent as DUSP7 depletion ([Figures S2D--S2F](#SD2){ref-type="supplementary-material"}). Based on these results, we hypothesized that DUSP7 promotes NEBD by dephosphorylating and inactivating cPKC isoforms. Consequently, cPKC isoforms should remain active in the absence of DUSP7. If this hypothesis holds true, inactivation of cPKC isoforms in DUSP7-depleted oocytes should rescue the depletion phenotype. We thus treated DUSP7-depleted oocytes with the cPKC inhibitor CGP-53353 ([@R64]). Increasing concentrations of the inhibitor partially rescued the number of oocytes that underwent NEBD ([Figure 2E](#F2){ref-type="fig"}). To confirm the specificity of this result, we co-depleted DUSP7 and PKCβ in follicles. In addition, the co-depletion of PKCβ rescued the efficiency of NEBD in DUSP7-depleted oocytes ([Figures S2H--S2L](#SD2){ref-type="supplementary-material"}). In both rescue conditions, the timing of NEBD was still slower than in controls ([Figure 2F](#F2){ref-type="fig"}; [Figure S2I](#SD2){ref-type="supplementary-material"}), which is likely due to increased, but overall lower, levels of Cdk1/CycB activity, as we discuss in more detail later.

To demonstrate the physiological relevance of these findings, we tested in vivo whether cPKC activity is increased in DUSP7-depleted oocytes. As a measure of cPKC activity, we used an antibody against auto-phosphorylated cPKC, because the degree of auto-phosphorylation represents an estimate of cPKC activity ([@R14]). In particular, we used an antibody specific for phosphorylated threonine 641 of PCKβ2 (pT641), which was also identified as DUSP7 target site by the in vitro phospho-peptide assay. We verified that this antibody is phospho-specific ([Figure S2M](#SD2){ref-type="supplementary-material"}). We found that the pT641 signal is increased in DUSP7-depleted compared to control-depleted oocytes ([Figures 2G and 2H](#F2){ref-type="fig"}). Moreover, in DUSP7-depleted samples only, we observed a second band above the phospho-PCKβ2 signal, which might represent a highly phosphorylated, active form of cPKC ([@R14]). The total protein level of PCKβ2 was unchanged, as judged by immunoblotting with a PKCβ2 antibody ([Figure 2G](#F2){ref-type="fig"}). Collectively, these results establish that DUSP7 dephosphorylates cPKC isoforms in mouse oocytes to facilitate NEBD.

Restoring Cdk1/CycB Activity in DUSP7-Depleted Oocytes Rescues DUSP7 Depletion {#S5}
------------------------------------------------------------------------------

Our in vitro phospho-peptide assay identified cPKC isoforms as DUSP7 targets. However, the mechanism by which DUSP7 depletion causes a prolonged meiotic arrest remained unclear. A prerequisite for NEBD is Cdk1/CycB activation. We speculated that the activity of Cdk1/CycB might be too low to support timely NEBD in DUSP7-depleted oocytes. We tested this hypothesis with a radioactive Cdk1 kinase assay using histone H1 as substrate ([Figure 3A](#F3){ref-type="fig"}; [Figure S3A](#SD2){ref-type="supplementary-material"}). In particular, we quantified Cdk1/CycB activity in mouse oocytes 6 hr after release from prophase arrest, because the Cdk1/CycB1 activity peaked at this time point in both conditions ([Figure S3A](#SD2){ref-type="supplementary-material"}). We found that Cdk1/CycB activity is reduced by around 40% in DUSP7-depleted oocytes ([Figure 3B](#F3){ref-type="fig"}). In addition, we performed the assay in the presence of the cPKC activator PMA and observed a similar decrease in Cdk1/CycB activity ([Figure 3C](#F3){ref-type="fig"}). We speculate that in the absence of DUSP7, Cdk1/CycB activity drops below the critical level required to resume meiosis. Expression of GFP-tagged wild-type DUSP7 restores Cdk1/CycB activity to levels that are sufficient to promote NEBD, but the overall level of activity may still be lower than in controls. This might be why DUSP7^wt^ expression or cPKC inhibition or depletion in DUSP7-depleted oocytes rescues the number of oocytes that undergo NEBD but does not restore normal timing of NEBD.

If the DUSP7 depletion phenotype is due to decreased Cdk1/CycB activity, increasing Cdk1/CycB activity should rescue the DUSP7 depletion phenotype. To test this, we artificially increased Cdk1/CycB activity to three levels ([Figure 3D](#F3){ref-type="fig"}). First, we increased the amount of wild-type Cdk1 protein (Cdk1^wt^). This should only result in a mild increase in Cdk1/CycB activity, because the kinases WEE1 and MYT1 still phosphorylate and thereby inhibit Cdk1^wt^ ([@R21]; [@R49]). Expression of Cdk1^wt^ did not change the percentage of oocytes that underwent NEBD ([Figure 3E](#F3){ref-type="fig"}) but caused a minor reduction in the timing of NEBD in DUSP7-depleted oocytes ([Figure 3F](#F3){ref-type="fig"}). Next, we expressed an active Cdk1 mutant that cannot be phosphorylated by WEE1 and MYT1 (Cdk1 T14A, Y15F: Cdk1^AF^). This should result in a strong increase of Cdk1/CycB activity ([@R54]). Control and DUSP7-depleted oocytes expressing GFP-Cdk1^AF^ underwent NEBD shortly after release from prophase arrest, when EGFP-expressing oocytes were still arrested ([Figure 3G](#F3){ref-type="fig"}). We obtained the same result when we expressed CDC25B, the phosphatase that activates Cdk1/CycB in mouse oocytes ([Figure S3B](#SD2){ref-type="supplementary-material"}) ([@R39]; [@R50]; [@R53]). Both conditions increase Cdk1/CycB activity to very high levels ([Figure 3D](#F3){ref-type="fig"}) and lead to a premature rescue of the DUSP7 depletion phenotype. Finally, we increased Cdk1/CycB activity to intermediate levels by expressing Cyclin B1, the co-activator of Cdk1 ([@R11]). Expression of mCherry-tagged Cyclin B1 (CycB1-mCherry) in DUSP7-depleted oocytes was able to fully rescue the DUSP7 depletion phenotype. The percentage of oocytes that underwent NEBD and the timing of NEBD were comparable to the results for control oocytes ([Figures 3I and 3J](#F3){ref-type="fig"}). This suggests that decreased Cdk1/CycB activity is the cause for the delay of NEBD in DUSP7-depleted oocytes.

The Spindle Assembly Checkpoint Is Compromised in DUSP7-Depleted Oocytes {#S6}
------------------------------------------------------------------------

DUSP7 depletion caused a second prominent phenotype, in addition to impairing meiotic resumption: the DUSP7-depleted oocytes that underwent NEBD often had misaligned chromosomes close to anaphase ([Figures 1A](#F1){ref-type="fig"}, inset, and [1E](#F1){ref-type="fig"}). In addition, the time from NEBD to anaphase was drastically shortened ([Figure 1F](#F1){ref-type="fig"}). These defects were specifically due to the depletion of DUSP7, because expression of wild-type (DUSP7^wt^) or ERK1/2 binding deficient (DUSP7^MBM^) DUSP7 partially rescued both defects ([Figures 1E and 1F](#F1){ref-type="fig"}). The rescue required the catalytic activity of DUSP7, because catalytically inactive DUSP7 (DUSP7^c.i.^) did not rescue the defects ([Figures 1E and 1F](#F1){ref-type="fig"}).

Chromosome alignment at the metaphase plate is preceded by the attachment of kinetochores to spindle microtubules. The spindle assembly checkpoint (SAC) delays anaphase onset in response to unattached chromosomes by generating an inhibitory signal ([@R32]; [@R63]; [@R66]). The kinetochore localized kinases MPS1 and Aurora B participate in both steps to promote the correct attachment and alignment of chromosomes on the metaphase plate. Inhibition of MPS1 has been reported to lead to chromosome misalignment and premature anaphase onset in mouse oocytes ([@R18]; [@R48]). Given that the depletion of DUSP7 results in chromosome misalignment and premature progression into anaphase, we investigated whether SAC signaling could be impaired in the absence of DUSP7. To test this possibility, we overexpressed a core component of the SAC: MAD1 (SNAP-tagged MAD1, SNAP-MAD1). MAD1 localizes to the kinetochores of unattached chromosomes, where it catalyzes the generation of the inhibitory signal ([@R33]; [@R60]). Overexpression of SAC components in mouse oocytes causes a metaphase arrest independently of misaligned chromosomes if the SAC is functional ([@R66]). As the SAC component, we decided to overexpress SNAP-MAD1, because it is also suitable to mark kinetochores of misaligned chromosomes by live cell microscopy ([@R7]). The expression of SNAP-MAD1 in control or DUSP7-depleted oocytes did not influence the number of oocytes undergoing NEBD or the timing of NEBD ([Figures S4A and S4B](#SD2){ref-type="supplementary-material"}). As expected, control oocytes expressing SNAP-MAD1 arrested in metaphase ([Figure 4B](#F4){ref-type="fig"}). In contrast, DUSP7-depleted oocytes expressing SNAP-MAD1 did not arrest in metaphase but progressed into anaphase after a delay ([Figure 4B](#F4){ref-type="fig"}; [Figure S4C](#SD2){ref-type="supplementary-material"}).

We then investigated the localization of SAC proteins. Control oocytes, as well as DUSP7-depleted oocytes, showed a positive SNAP-MAD1 signal at kinetochores shortly after NEBD ([Figure 4A](#F4){ref-type="fig"}; [Figure S4D](#SD2){ref-type="supplementary-material"}). This confirms that the initial recruitment of SAC components to the kinetochore is not altered in the absence of DUSP7. Misaligned chromosomes in control oocytes are rare and can only be observed transiently upon formation of a metaphase plate in control oocytes ([@R7]). However, previous studies showed that they are positive for MAD1 ([@R7]; [@R70]). Consistent with these studies, 81% (9 of 11 recordings) of misaligned chromosomes in 33 control oocytes were positive for MAD1 ([Figure S4E](#SD2){ref-type="supplementary-material"}). By contrast, only 26% (5 of 19 recordings) of misaligned chromosomes in 28 DUSP7-depleted oocytes were positive for MAD1 ([Figure S4E](#SD2){ref-type="supplementary-material"}). These data suggest that SAC proteins are not efficiently retained at misaligned kinetochores in the absence of DUSP7. If this holds true, inactivating the SAC by other means should show a similar phenotype. Inhibition of the kinase MPS1 is known to disturb SAC signaling in mouse oocytes, and the oocytes progress into anaphase in the presence of misaligned chromosomes ([@R18]). Depletion of DUSP7 or MPS1 resulted in a similar time from NEBD to anaphase ([Figure 4C](#F4){ref-type="fig"}). Co-depletion of MPS1 in DUSP7-depleted oocytes reduced the time of anaphase further, possibly due to a more complete inactivation of the checkpoint ([Figure 4C](#F4){ref-type="fig"}). Both MPS1 and DUSP7 depletion caused chromosome alignment defects. The percentage of oocytes with misaligned chromosomes was higher in MPS1-depleted oocytes than in DUSP7-depleted oocytes and did not increase further upon co-depletion ([Figure 4D](#F4){ref-type="fig"}). The number of oocytes undergoing NEBD and the time from release to NEBD were not influenced by MPS1 depletion ([Figures S4F and S4G](#SD2){ref-type="supplementary-material"}). However, the overall phenotypes were similar, consistent with impaired SAC signaling in DUSP7-depleted oocytes.

A key target in SAC signaling is the APC/C. The APC/C is a multi-subunit ubiquitin ligase that regulates the onset of anaphase by targeting the anaphase inhibitor securin and other M-phase substrates for degradation ([@R4]; [@R55]). The SAC delays anaphase by inhibiting the APC/C until the chromosomes are correctly attached to the spindle. If SAC signaling is compromised in DUSP7-depleted oocytes, the APC/C should be inefficiently inhibited. Therefore, the APC/C should trigger the degradation of its substrates earlier than under normal conditions. A well-known substrate of the APC/C is CycB1, the co-activator of Cdk1. We expressed CycB1-mCherry in control and DUSP7-depleted oocytes ([Figures 4E and 4F](#F4){ref-type="fig"}). As predicted, the APC/C was activated earlier in DUSP7-depleted oocytes, as reflected by a significantly earlier onset of CycB1-mCherry degradation.

The decreased activity of the SAC could also be a consequence of the lower Cdk1/CycB activity that we observed in DUSP7-depleted oocytes ([Figure 3A](#F3){ref-type="fig"}) ([@R9]; [@R46]; [@R56]). However, upregulation of Cdk1/CycB activity or inhibition of cPKC isoforms did not restore normal chromosome alignment in DUSP7-depleted oocytes ([Figures 3H and 3K](#F3){ref-type="fig"}; [Figures S2G and S2J](#SD2){ref-type="supplementary-material"}). In addition, the time from NEBD to anaphase was not rescued when Cdk1/CycB activity was increased ([Figures S2K, S3C, and S3D](#SD2){ref-type="supplementary-material"}). These results suggest that the defects in SAC signaling are not solely due to a decrease in Cdk1/CycB in the absence of DUSP7.

Discussion {#S7}
==========

The tight and reliable control of meiotic resumption is crucial for reproduction. Although defects in meiotic resumption have been implicated in infertility ([@R25]; [@R26]; [@R47]; [@R58]), the molecular mechanisms that drive the reinitiation of meiosis are still incompletely understood. Our results provide mechanistic insights into how the prophase arrest in oocytes is abrogated.

We identified an unexpected signaling pathway that is essential for the release from prophase arrest. In this pathway, DUSP7 drives meiotic resumption by dephosphorylating and thereby inactivating cPKC isoforms, which is essential for timely NEBD. This pathway is likely to be crucial for meiosis, because a DUSP7 knockout mouse created by the International Mouse Phenotyping Consortium has been reported to be infertile. The DUSP7-dependent pathway could act in parallel to the canonical Cdk1/CycB activation mechanism that has been implicated in the release from prophase arrest. In the canonical pathway, cyclic AMP-activated protein kinase A (PKA) activates WEE1, which inhibits Cdk1/CycB and thereby prevents meiotic resumption ([@R20]; [@R49]). After the LH surge, PKA and consequently WEE1 are inactivated and Cdk1/CycB becomes active. Having two parallel pathways that control meiotic resumption may allow oocytes to trigger the release from prophase arrest more robustly and to integrate more signals before oocytes are allowed to resume meiosis. This may reduce the risk of precocious meiotic resumption and increase the chance of conception.

DUSP7 promotes the release from prophase arrest by dephosphorylating and thereby inhibiting cPKC isoforms, a prerequisite for the timely activation of Cdk1/CycB. But what is the link between cPKC isoforms and Cdk1/CycB? Protein kinase C (PKC) α and PKCδ are known to regulate the Cdk inhibitors p21(CIP) and p27(Kip1) ([@R12]; [@R16]). p21(CIP) controls the G2/M transition in mouse spermatogenesis ([@R29]), and p27(Kip1) is required for prophase arrest in *Drosophila* oogenesis ([@R24]). It is thus conceivable that DUSP7 could regulate Cdk1/CycB activity by suppressing an inhibitor of Cdk1/CycB, such as p21 and p27, via cPKC isoforms. In addition, cPKC isoforms can influence the activity of the Cdk1/CycB-activating phosphatase CDC25. They can do so by regulating the activity of CDC25 directly ([@R68]) or by suppressing its expression ([@R69]). DUSP7 may thus be essential for the timely activation of CDC25.

In addition to a delay or a block in NEBD, we frequently observed misaligned chromosomes and premature progression into anaphase in oocytes depleted of DUSP7 ([Figure 4](#F4){ref-type="fig"}). The SAC arrests mouse oocytes in metaphase until the chromosomes are attached to the meiotic spindle ([@R66]). However, evidence suggests that the SAC in mammalian oocytes is not as stringent as in mitotic cells and some misaligned chromosomes might remain undetected ([@R30]; [@R31]; [@R37]; [@R52]; [@R72]). Many proteins that participate in the SAC are regulated by phosphorylation ([@R17]; [@R41]). Consequently, protein phosphatases play a major role in regulating SAC signaling. For example, protein phosphatase 1 removes the phosphorylation on the kinetochore component KNL1 to facilitate stable microtubule attachments and SAC silencing ([@R40]). In contrast, BubR1 needs to remain phosphorylated to recruit PP2A-B56, which in turn helps to stabilize microtubule attachments ([@R61]). It is tempting to speculate that DUSP7 contributes to some of these processes. In our in vitro phospho-peptide screen, we did not detect SAC components as potential DUSP7 substrates, even though some were included in the assay (e.g., components of the RZZ complex). We also did not observe a localization of DUSP7 to kinetochores. Instead, DUSP7 remained cytoplasmic in all cell-cycle phases ([@R52]). This could suggest that DUSP7 participates not directly in the SAC but indirectly, for example, by regulating other protein kinases or phosphatases.

Alternatively, a weakened SAC response in DUSP7-depleted oocytes could be a consequence of decreased Cdk1/CycB activity ([@R9]; [@R46]; [@R56]). It was shown that lowering Cdk1/CycB activity leads to an earlier onset of anaphase, even in the presence of misaligned chromosomes. Increasing Cdk1/CycB activity in bub1^Δ/Δ^ mice ([@R56]) restored the function of the SAC but required a non-degradable version of Cyclin B, artificially enhancing Cdk1/CycB activity. We were able to rescue the timing of NEBD in the absence of DUSP7 by increasing Cdk1/CycB activity using wild-type Cyclin B1 but could not restore a normal SAC response. While these results indicate that the decrease in Cdk1/CycB activity is not the primary cause of the impaired SAC response in the absence of DUSP7, a further increase in Cdk1/CycB activity might restore a normal SAC function.

DUSP7 is also expressed in human oocytes ([@R43]; [@R71]), suggesting that its function may be preserved. An important factor that contributes to female infertility in humans is the inability of an oocyte to resume meiosis ([@R3]; [@R26]; [@R27]). It is likely that the malfunction of proteins that are only essential in the oocyte, not in other parts of the body, contributes to this defect. DUSP7 is an excellent candidate for such a protein, because DUSP7 mutant mice are viable but infertile, suggesting that DUSP7 functions primarily in the germline. Analysis of DUSP7's function in humans will be crucial for understanding whether this pathway for meiotic resumption is conserved and whether defects in DUSP7 could contribute to infertility.

Experimental Procedures {#S8}
=======================

Preparation and Culture of Follicles, RNAi Sequences, and Drug Treatment of Oocytes {#S9}
-----------------------------------------------------------------------------------

All mice were maintained in a specific pathogen-free environment according to UK Home Office regulations. The work with mice was carried out at the Medical Research Council (MRC) Laboratory of Molecular Biology following the specifications of the UK Home Office. The project license was approved by the UK Home Office and evaluated by the MRC Cambridge Ethics Committee. The preparation of follicles and their culture is described in [@R52]. RNAi depletion was performed for 10 days using a final concentration of 50 nM short interfering RNA oligonucleotide (oligo) in the oocyte. The RNAi oligo sequences for DUSP7, Epha4, and Mps1 are described in [@R52]. PLCγ1 was depleted with an oligo mix targeting the sequences 5′-ACGGAAGACCTTCCAGGTCAA-3′, 5′-CCGGGCTGAGGGAAA GATCAA-3′, 5′-CACCGTCATGACTTTGTTCTA-3′, and 5′-CAGGAGGAAGATCCTTATTAA-3′. PKCβ isoforms 1 and 2 were depleted with an oligo mix targeting the sequences 5′-AAGGACCCTGATTCTACATTA-3′, 5′-CCAGTCAAT CATGGAACACAA-3′, 5′-CTGCTGCTTTGTTGTACACAA-30, and 5′-CCGGAGCAAACACAAGTTTAA-3′. All RNAi oligos were obtained from QIAGEN.

Oocytes treated with PMA or CGP-53353 (Sigma) were incubated with the drug for 1 hr before release. During release and imaging, the drug was still present.

Confocal Microscopy and Image Preparation {#S10}
-----------------------------------------

Confocal microscopy was performed as described in [@R52]. All oocytes were recorded at least for 14 hr. For some movies, a Leica SP8 inverted confocal microscope equipped with a heated environmental chamber and a motorized stage was used. Imaging was performed with a Leica 40×/1.1 numerical aperture (NA) water immersion objective.

All movies were analyzed and prepared using ImageJ (NIH) and Photoshop (Adobe). If the contrast or the brightness were adjusted, the procedure was applied to the whole image or image sequence. The intensity of bands from auto-radiograms or immunoblots was measured using ImageJ and corrected for background signal and loading control.

mRNA Preparation and Injection {#S11}
------------------------------

mRNA was prepared with the mMessage mMachine Kit (Ambion), precipitated with LiCl, and taken up in 20 μL of RNase-free water. Quantitative microinjection was performed as described ([@R28]). After injection of mRNAs into oocytes, expression was performed for at least 4 hr at 37°C.

Immunoblotting {#S12}
--------------

All samples were mixed with NuPAGE sample loading buffer (Invitrogen) and heated at 95°C for 5 min. Antibodies used for western blotting were anti-FLAG M2 (mouse, Sigma), anti-ERK2 (rabbit, Santa Cruz), anti-α-tubulin (rat, AbD Serotec), anti-PKCβ2 C-terminal (rabbit, Santa Cruz), anti-CDK1 (mouse, Santa Cruz), anti-CDC25B (rabbit, Cell Signaling Technology), and anti-pT641 PKCα/β2 (rabbit, Cell Signaling Technology). All primary antibodies were used in 5% dry milk in PBS with 0.1% Tween 20 and incubated overnight at 4°C. Horseradish peroxidase-coupled secondary anti-mouse (Dako), anti-rabbit (Fisher), and anti-rat (Santa Cruz) antibodies were detected by enhanced chemiluminescence (ECL select, GE Healthcare) and Biomark X-ray (Carestream) or Super RX-N (Fujifilm) films.

Statistical Analysis {#S13}
--------------------

All diagrams were generated using Origin 8 Pro (Origin Software). Boxplots show the first to third quartiles; the median is indicated by a line and the mean is indicated by a square. Error bars on the boxplot denote the 5^th^ and 95^th^ percentiles. For all data shown as boxplots, a two-tailed Student's t test was performed to determine significance. To test significance for all data shown in bar graphs, a Fisher's exact test was performed. One star indicates significance smaller than 5 × 10^−2^, two stars indicate significance smaller than 1 × 10^−3^, and three stars indicate significance smaller than 1 × 10^−4^. All experiments were repeated at least two times, and each number in brackets above the graphs denotes the number of all oocytes used for the analysis, except in [Figure 3B](#F3){ref-type="fig"} and [Figures S1A, S2L, and S4D](#SD2){ref-type="supplementary-material"}, where the number of experiments is given.
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###### Highlights

-   The phosphatase DUSP7 is an essential regulator of meiotic resumption

-   DUSP7 dephosphorylates and inactivates cPKC isoforms

-   Inactivation of cPKC isoforms is essential for the timely activation of Cdk1/CycB

![DUSP7 Is Required for Normal NEBD and Chromosome Alignment\
(A) Follicles were isolated and microinjected with scrambled (*scr*) or *Dusp7* RNAi. After 10 days of culture, the surrounding somatic cells were removed and the mature oocytes were microinjected again with H2B-mCherry to label the chromosomes and EGFP-MAP4 to label the meiotic spindle (not shown). In addition, EGFP-tagged DUSP7 rescue constructs were microinjected (see B--F). After 5 hr of mRNA expression, the oocytes were released from prophase arrest and imaged on a confocal microscope. Representative images from these movies are shown. The nucleus is highlighted with a dotted line. Misaligned chromosomes are magnified in the inset. Oil droplets that result from microinjection are visible in some pictures but not marked. Time is given in hours and minutes. Scale bar represents 10 μm. The full movies are available as [Movies S1](#SD3){ref-type="supplementary-material"}, [S2](#SD4){ref-type="supplementary-material"}, and [S3](#SD5){ref-type="supplementary-material"}. The experiment was repeated five times.\
(B) Oocytes were treated as in (A), and the percentage of oocytes that underwent NEBD was scored at the end of the imaging. The rescue constructs were wild-type DUSP7 (wt), catalytically inactive DUSP7 (c.i.), and the MAPK binding mutant DUSP7 (MBM). A minus (−) denotes expression of EGFP alone, without DUSP7.\
(C) Oocytes were treated as in (A), and the same rescue constructs as in (B) were microinjected. The time from the release from prophase arrest until NEBD is shown in hours.\
(D) The indicated FLAG-tagged DUSP7 constructs were expressed, together with ERK2 in HeLa cells. FLAG-DUSP7 was immunoprecipitated using anti-FLAG antibodies from the cell lysate. The input and the precipitated fraction were blotted with the indicated antibodies to test for the presence of ERK2 associated with DUSP7. DUSP7^MBM^ seems to be less expressed in HeLa cells than DUSP7^wt^ and DUSP7^c.i.^. However, no difference was observed in the ability to bind to the immunoprecipitation matrix. The experiment was repeated two times.\
(E) Oocytes were treated as described in (A) and (B). Oocytes that underwent NEBD were analyzed for the presence of misaligned chromosomes in the frame before the onset of anaphase.\
(F) Oocytes were treated as described in (A) and (B). The time that the oocytes needed from NEBD to anaphase was analyzed and is shown in hours.](emss-70831-f001){#F1}

![Inactivation of cPKC Isoforms Rescues DUSP7 Depletion\
(A) Venn diagram showing the distribution of hits from five independent in vitro phospho-peptide screening assays. Intersections between two or more assays show hits that were found in all these assays. Proteins that were found in at least three assays are highlighted.\
(B) Mature oocytes were isolated and microinjected with H2B-mCherry and EGFP-MAP4. After mRNA expression, the oocytes were released in the presence of DMSO or PMA and imaged on a confocal microscope. The percentage of oocytes that underwent NEBD was scored at the end of the imaging. The experiment was repeated four times.\
(C) Oocytes from (B) were analyzed for the time (in hours) from release from prophase arrest to NEBD.\
(D) Oocytes from (B) that underwent NEBD were analyzed for the time spent between NEBD and anaphase.\
(E) Follicles were isolated and microinjected with scrambled (*scr*) or *Dusp7* RNAi and cultured. The mature oocytes were microinjected a second time with H2B-mCherry and EGFP-MAP4. After mRNA expression, the oocytes were released in the presence of DMSO or the indicated concentrations of the cPKC inhibitor CGP-53353 and imaged on a confocal microscope. The percentage of oocytes that underwent NEBD was scored at the end of the imaging. The experiment was repeated five times.\
(F) Oocytes from (E) were analyzed for their time from release from prophase arrest to NEBD.\
(G) Follicles were treated as described in (E) but not microinjected a second time. The oocytes were lysed in Laemmli sample buffer and blotted for the indicated proteins. For the *scr* RNAi-treated lane, 18 oocytes were used; for the *Dusp7* RNAi group, 21 oocytes were used.\
(H) The mean intensities of the pT641 PKCβ2 and the PKCβ2 bands from the immunoblot shown in (G) were quantified. The ratio of the lower band and the upper band in the pT641 PKCβ2 blot to the PKCβ2 band was calculated and is shown.](emss-70831-f002){#F2}

![Increased Cdk1/CycB Activity Rescues DUSP7 Depletion\
(A) Follicles were depleted of DUSP7 or microinjected with scrambled (*scr*) RNAi. After culture, the oocytes were released and snap frozen at the indicated time points. The auto-radiogram shows the incorporation of radioactive phosphate into histone H1. Coomassie brilliant blue (CBB) staining shows histone H1.\
(B) The intensity of the radioactive histone H1 signal at 6 hr after release was measured and normalized to histone H1 protein. The experiment was repeated three times.\
(C) Mature oocytes were isolated and released in the presence of either DMSO or the cPKC activator PMA. Oocytes were snap frozen at the indicated time points. The auto-radiogram shows the incorporation of radioactive phosphate into histone H1. CBB staining shows histone H1.\
(D) Scheme showing the different constructs to modulate Cdk1/CycB kinase activity and the expected relative increase of Cdk1/CycB activity. A + sign indicates a mild increase, ++ indicates a medium increase and +++ stands for Cdk1/CycB hyper-activation.\
(E) Follicles were depleted as described in (A) but microinjected a second time after isolation with H2B-mCherry and GFP or GFP-Cdk1 wild-type (Cdk1^wt^). After mRNA expression, the oocytes were released and imaged on a confocal microscope. The percentage of oocytes that underwent NEBD was scored at the end of the imaging. The experiment was repeated three times.\
(F) Follicles were treated as in (E), and the time from release from prophase arrest to NEBD was measured.\
(G) Follicles were treated as in (E). GFP-tagged hyper-active Cdk1 (Cdk1^AF^) was microinjected in a separate group of oocytes. This group underwent NEBD before imaging at the microscope was started, and analysis of the timing was therefore not possible. Instead, all oocytes that underwent NEBD within a time frame of 60 min after release (and within 30 min intervals afterward) were grouped together. The cumulative percentage of oocytes that underwent NEBD after the indicated time is shown.\
(H) Oocytes from (E) that performed NEBD were analyzed for the presence of misaligned chromosomes in the frame before the onset of anaphase.\
(I) Follicles were treated as in (E) but microinjected with H2B-mCherry and CycB1-mCherry. After mRNA expression, the oocytes were released and imaged on a confocal microscope. The percentage of oocytes that underwent NEBD was scored at the end of the imaging. The experiment was repeated five times.\
(J) Oocytes from (I) were analyzed for the time from release from prophase arrest to NEBD.\
(K) Oocytes from (I) that performed NEBD were analyzed for the presence of misaligned chromosomes in the frame before the onset of anaphase.](emss-70831-f003){#F3}

![DUSP7 Participates in the SAC Response in Mouse Oocytes\
(A) Follicles were microinjected with scrambled (*scr*) or *Dusp7* RNAi and cultured. The somatic cells were removed and the oocytes were microinjected a second time with H2B-mCherry to mark the chromosomes and SNAP-tagged MAD1 (SNAP-MAD1). After mRNA expression, the SNAP tag was labeled with SNAP-Cell 505 Star. The oocytes were released and imaged on a confocal microscope. Representative images of these movies are shown. Misaligned chromosomes are highlighted with white arrowheads. Time is given in hours and minutes. Scale bar represents 10 μm. The inset shows a magnification of one misaligned chromosome per group. The channel for SNAP-MAD1 in the inset was adjusted in brightness to visualize MAD1 better. The full movies are available as [Movies S4](#SD6){ref-type="supplementary-material"} and [S5](#SD7){ref-type="supplementary-material"}. The experiment was repeated four times.\
(B) Oocytes from (A) and additional oocytes treated in the same way but microinjected with EGFP alone were analyzed for their progression into anaphase.\
(C) Follicles were microinjected with scrambled (*scr*), *Dusp7*, and/or *Mps1* siRNAs and cultured. The oocytes were microinjected with H2B-mCherry and EGFP-MAP4. After mRNA expression, the oocytes were released and imaged on a confocal microscope. Their time from release from prophase arrest to anaphase was analyzed. The experiment was repeated four times.\
(D) The same oocytes as in (C) were analyzed for the presence of misaligned chromosomes in the last frame before anaphase.\
(E) Representative images from oocytes used in [Figure 3I](#F3){ref-type="fig"} to illustrate the earlier onset of CycB1-mCherry degradation in DUSP7-depleted oocytes.\
(F) The CycB1-mCherry fluorescence was measured in oocytes from [Figure 3I](#F3){ref-type="fig"} as described in [@R34]. The average fluorescence intensity at NEBD was set to 100%.](emss-70831-f004){#F4}
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